NCT03344913

Brief Summary

Osteoarthritis (OA) in the knee is characterized by chronic inflammatory pain that is not necessarily related to the amount of joint damage. Clinical practice guidelines recommend physical activity (PA) for osteoarthritis pain, but most adults with OA do not engage in PA. One reason for this is that while PA can reduce OA related joint pain, it does not work for everyone. PA decreases pain sensitivity for about half of adults with OA but increases pain sensitivity for the other half. The investigators are hypothesizing that individual differences in how well cells work to make energy, inflammation, and different proteins available in blood cells explains who PA will work to reduce pain and who it won't among adults with OA. The purpose of this pilot study is to determine if blood cells' ability to make cellular energy, inflammation and proteins help explain the difference about who PA reduces activity for and who it doesn't. The investigators will compare these biologic factors and pain sensitivity before walking, immediately after 30 minutes of walking (i.e. "acute") and after six weeks of walking three times a week for 30 minutes (i.e. "long-term") in adults with hip or knee osteoarthritis. The investigators will also compare these results to adults without OA. The investigators will recruit a sample of 40 adults with radiologic (e.g x-ray or CT scan) evidence of hip or knee OA and 20 age/gender matched healthy adults without OA to address the following study aims: Aim 1: To examine the effects of a six week (three days/week) walking program on pain in adults with OA as compared to healthy controls. Aim 2: To test the cells' ability to make energy as a mechanism for variation in pain after "acute" and "long-term" PA in older adults with lower extremity osteoarthritis. Aim3: To test the role of inflammation as a mechanism for variation in pain after "acute" and "long-term" physical activity in adults with lower extremity osteoarthritis. Aim 4: To generate hypotheses regarding the role of proteomics in variation in pain after "acute" and "long-term" physical activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 17, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

May 7, 2018

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 24, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 24, 2022

Completed
Last Updated

September 7, 2022

Status Verified

September 1, 2022

Enrollment Period

4.3 years

First QC Date

November 8, 2017

Last Update Submit

September 6, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain sensitivity

    Change from baseline pain threshold/tolerance after 30 minutes of walking

    Baseline and immediately after 30 minutes of walking

  • Pain sensitivity

    Change from baseline pain threshold/tolerance after six weeks of walking for 30 minutes three days/week

    Baseline and within 4 weeks after completing six weeks of walking for 30 minutes three days/week

Secondary Outcomes (6)

  • platelet mitochondrial function

    immediately after 30 minutes of walking

  • platelet mitochondrial function

    after six weeks of walking for 30 minutes

  • Inflammatory markers in plasma

    immediately after 30 minutes of walking

  • Inflammatory markers in plasma

    after six weeks of walking for 30 minutes

  • Platelet protein signatures

    immediately after 30 minutes of walking

  • +1 more secondary outcomes

Study Arms (2)

Adults with knee Osteoarthritis

ACTIVE COMPARATOR

walking 30 minutes per day, three days/week for 6 weeks.

Behavioral: Walking

Healthy controls

ACTIVE COMPARATOR

walking 30 minutes per day, three days/week for 6 weeks.

Behavioral: Walking

Interventions

WalkingBEHAVIORAL

walking 30 minutes per day, three days/week for 6 weeks with a member of study team.

Adults with knee OsteoarthritisHealthy controls

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with Osteoarthritis:
  • Age 50-80
  • radiographic evidence of knee osteoarthritis (OA participants)
  • self-report current non-smoker
  • willing and able to walk for 30 minutes a day three days a week for six weeks at a location that is within 30 minutes from University of Maryland Baltimore
  • speaks English
  • Healthy Controls:
  • Age 50-80
  • self-reports no osteoarthritis
  • self-report current non-smoker
  • willing and able to walk for 30 minutes a day three days a week for six weeks at a location that is within 30 minutes from University of Maryland Baltimore
  • speaks English

You may not qualify if:

  • unable to pass the evaluation to sign consent
  • diagnosis of rheumatoid arthritis
  • diagnosis of gout
  • diagnosis of heart failure
  • diagnosis of chronic obstructive pulmonary disease
  • diagnosis of diabetes
  • diagnosis of Parkinson's disease
  • diagnosis of Alzheimer's disease
  • diagnosis of autoimmune disease
  • currently taking long-term steroid medications such as methotrexate
  • weight less than 110 lbs.
  • direct employee of the PI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland, Baltimore

Baltimore, Maryland, 21201, United States

Location

Related Publications (1)

  • Klinedinst NJ, Huang W, Nelson AK, Resnick B, Renn C, Kane MA, Dorsey SG. Inflammatory and Immune Protein Pathways Possible Mechanisms for Pain Following Walking in Knee Osteoarthritis. Nurs Res. 2022 Jul-Aug 01;71(4):328-335. doi: 10.1097/NNR.0000000000000593. Epub 2022 Mar 18.

MeSH Terms

Conditions

Osteoarthritis, KneePainMotor Activity

Interventions

Walking

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Jennifer Klinedinst, PhD

    University of Maryland, Baltimore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Adults with knee osteoarthritis and healthy controls will both undergo the same walking intervention. The goal is to examine basic mechanism for pain sensitivity after walking.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 8, 2017

First Posted

November 17, 2017

Study Start

May 7, 2018

Primary Completion

August 24, 2022

Study Completion

August 24, 2022

Last Updated

September 7, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

This is a pilot study with a very small sample size.

Locations